ナビゲーション
市場の見通し ストックスクリーナー 配当カレンダー イベントカレンダー 株式の格付け マーケットニュース
無料でお試しください

NovaBay Pharmaceuticals

AMEX NBY
$0.08 0.0033 3.93%
Today share price
米国
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 25 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

2.07M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
574.45K
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
3.73
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
24.67M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-58.82 %

Upcoming events NovaBay Pharmaceuticals

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart NovaBay Pharmaceuticals

Stock analysis NovaBay Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

もっと
-0.16 -0.15
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

もっと
0.63 0.56
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

もっと
-0.12 -4.23
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

もっと
0.32 0.42
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

もっと
-8,194.37 -51.45

Price change NovaBay Pharmaceuticals per year

0.52$ 1.62$
Min Max

Summary analysis NovaBay Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure NovaBay Pharmaceuticals

Revenue and net income NovaBay Pharmaceuticals

All parameters

Stock news NovaBay Pharmaceuticals

All news
7 10月 2022 в 23:26

NovaBay Pharmaceuticals to Seek Reverse Stock Split

7 10月 2022 в 23:26

NovaBay Pharmaceuticals to Seek Reverse Stock Split

About company NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc., a medical device company, develops products for the eye care markets in the United States and internationally. The company offers Avenova, a solution for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye, including the eyelid; CelleRx Clinical Reset, a gentle and soothing facial spray; and NeutroPhase and PhaseOne for the wound care market. It also offers KN95 Masks. The company sells its products through distribution partners, as well as offers Avenova and CelleRx Clinical Reset through online sales channels. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Address:
2000 Powell Street, EmeryVille, CA, United States, 94608
Company name: NovaBay Pharmaceuticals
Issuer ticker: NBY
ISIN: US66987P2011
Country: 米国
Exchange: AMEX
Currency: $
IPO date: 2007-10-26
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.novabay.com

On which stock exchange are NovaBay Pharmaceuticals (NBY) stocks traded?

NovaBay Pharmaceuticals (NBY) stocks are traded on AMEX.

What is the ticker of NovaBay Pharmaceuticals stocks (NBY)?

The stock ticker of NovaBay Pharmaceuticals’s stocks or in other words, the code is NBY. The stocks are currently listed on the AMEX exchange.

In which sector and industry does NovaBay Pharmaceuticals (NBY) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, NovaBay Pharmaceuticals (NBY) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are NovaBay Pharmaceuticals (NBY) stocks traded?

NovaBay Pharmaceuticals (NBY) stocks are traded on the AMEX exchange in dollars.

What is the price of NovaBay Pharmaceuticals (NBY) stocks today?

The current price of NovaBay Pharmaceuticals stocks on 15.05.2024 is 0.084 dollars. per share.

What is the dynamics of NovaBay Pharmaceuticals (NBY) stocks from the beginning of the year?

NovaBay Pharmaceuticals (NBY) quotes have increased by -56.83% from the beginning of the year up to 0.084 dollars. per 1 stocks.

How much did NovaBay Pharmaceuticals (NBY) stocks increase in мае 2024?

This month NovaBay Pharmaceuticals (NBY) quotes have increased by -6.25% to 0.084 dollars. per share.

How much are NovaBay Pharmaceuticals (NBY) stocks worth?

Today, on October, 15.05.2024 NovaBay Pharmaceuticals’s (NBY) stocks cost 0.084 dollars..

What is the market capitalization of NovaBay Pharmaceuticals (NBY)?

Capitalization is the market value of NovaBay Pharmaceuticals (NBY) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 15.05.2024, the market capitalization of NovaBay Pharmaceuticals (NBY) is estimated at about 2072448 dollars.